- Population-based patient care research
- Drug safety and patient empowerment
- Access to care and medications in underserved and special populations
- +۲ مورد دیگر
Professor Kim Eun-kyung is a full-time Professor at the College of Pharmacy , Seoul National University , South Korea. She directs patient-oriented research at the intersection of pharmacy, public health and clinical epidemiology, leading projects that range from nationwide pharmaco-epidemiologic cohort analyses to qualitative investigations of pharmacist-led care models. Education Ph.D. & Pharm.D., University of Florida, USA Research Interests Professor Kim’s research program is built on five mutually reinforcing pillars: Population-based patient care research – leveraging large national databases to understand medication utilization and outcomes in real-world settings. Drug safety and patient empowerment – identifying adverse drug reactions and developing interventions that enable consumers and clinicians to report and prevent harm. Access to care and medications in underserved and special populations – examining barriers faced by the elderly, rural residents, patients with rare diseases, and those undergoing high-cost procedures such as hematopoietic stem-cell transplantation. Disease prevention and appropriateness of therapy – evaluating preventive pharmacotherapy (e.g., anti-osteoporosis drugs, vitamin D) and ensuring evidence-based prescribing. Quality improvement in health-care delivery – designing multidisciplinary models that integrate pharmacists into care teams to optimize medication therapy and reduce drug-related problems. Publication Trends Across 2017–2020, Professor Kim has published extensively in International Journal of Environmental Research and Public Health , Clinical Nutrition , Medicina , BMC Public Health , Blood Research , Neuroepidemiology and other peer-reviewed journals. Her work characteristically combines rigorous secondary-data analyses of Korean or US national health surveys with systematic reviews/meta-analyses focusing on drug safety endpoints. Themes include neurological adverse events (trimetazidine-induced parkinsonism), hematologic toxicities (linezolid-induced thrombocytopenia), nutritional and metabolic complications in critical care, and access/utilization of medications in vulnerable populations. Scientific Awards & Honors (None listed in the provided texts) Grants & Research Support While specific grant identifiers are not detailed in the supplied pages, the breadth of large-scale database studies and multi-institutional collaborative projects implies sustained funding from national agencies such as the Korea Health Industry Development Institute (KHIDI) or the Ministry of Health & Welfare. Laboratory & Team Professor Kim leads an active research group located in Yeongeon Campus 17-201. The team integrates graduate students, post-doctoral researchers, pharmacists and biostatisticians working together on pharmacoepidemiology, patient-reported outcomes and health-services research.








